Altogether, these data demonstrate the contribution of SGLT1 to tamoxifen resistance in ER-positive breast cancer cells and, moreover, support the importance of the positive feedback loop identified between breast carcinoma cells and M2-like TAMs (Fig. 6). The gene discussed is SLC5A1; the disease is breast carcinoma.